Mycophenolate mofetil reduces the risk of acute rejection less in African-American than in Caucasian kidney recipients.

E J Schweitzer; S Yoon; J Fink; A Wiland; L Anderson; P C Kuo; J W Lim; L B Johnson; A C Farney; M R Weir

doi:10.1097/00007890-199801270-00017

Mycophenolate mofetil reduces the risk of acute rejection less in African-American than in Caucasian kidney recipients.

Identifier:nobleid.org/w1/20260515/D1330833

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D1330833.svg?ark=w1%2F20260515%2FD1330833)](https://nobleid.org/work/w1/20260515/D1330833)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Mycophenolate mofetil reduces the risk of acute rejection less in African-American than in Caucasian kidney recipients.

Identifier:nobleid.org/w1/20260515/D1330833

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/D1330833.svg?ark=w1%2F20260515%2FD1330833)](https://nobleid.org/work/w1/20260515/D1330833)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work